PG
DGX icon

Pendal Group’s Quest Diagnostics DGX Stock Holding History

Pendal Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$313K Buy
+2,001
New +$288K ﹤0.01% 434
2022
Q2 		– Sell
-5,272
Closed -$722K – 467
2022
Q1 		$722K Buy
+5,272
New +$735K 0.01% 363
2021
Q2 		– Sell
-8,177
Closed -$1.05M – 562
2021
Q1 		$1.05M Sell
8,177
-816
-9% -$101K 0.01% 314
2020
Q4 		$1.07M Buy
+8,993
New +$1.1M 0.01% 285
2017
Q3 		– Sell
-33,883
Closed -$3.77M – 459
2017
Q2 		$3.77M Buy
+33,883
New +$3.58M 0.05% 190

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pendal Group's DGX Position: Q4 2022 in Review

Pendal Group opened a new position in Quest Diagnostics (DGX) in Q4 2022: 2,001 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #434 among its holdings. This is a return to the name: Pendal Group previously reported a position in DGX as recently as Q1 2022.

Pendal Group first reported a position in DGX in Q2 2017 and has held it in 5 quarters since. The position peaked at $3.77M in Q2 2017. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Pendal Group held 2,001 shares of Quest Diagnostics worth $313K as of Q4 2022.
  • Quest Diagnostics was a new Pendal Group position in Q4 2022.
  • Quest Diagnostics made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #434 holding.
  • Pendal Group first reported a position in Quest Diagnostics in Q2 2017 and has held it in 5 quarters since.
  • Pendal Group's Quest Diagnostics position peaked at $3.77M in Q2 2017.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.